CELULARITY IMPACT - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Image for trademark with serial number 97265928
Serial Number
97265928
Word Mark
CELULARITY IMPACT
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2022-02-18
Filing Date
2022-02-14
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Statements
Goods and Services
Manufacturing services for others in the fields of cell therapy, modified cell therapy, gene therapy, tissue engineering, biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
Goods and Services
Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing written materials and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; good manufacturing practices (GMP) laboratory testing and analytical services; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2022-02-18
Primary Code
040
First Use Anywhere Date
2019-03-29
First Use In Commerce Date
2019-03-29
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2022-02-18
Primary Code
042
First Use Anywhere Date
2019-03-29
First Use In Commerce Date
2019-03-29
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
CAMILLE M. MILLER
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration5957944
Prior Registration6102576
Prior Registration6260135
Trademark Events
Event DateEvent Description
2022-02-17NEW APPLICATION ENTERED IN TRAM
2022-02-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM